Mid-Florida Medical Specialties Inc Kissimmee, FL - 34758

Mid-Florida Medical Specialties Inc is categorized under Health Services in Kissimmee, FL and active since 2012.

Mid-Florida Medical Specialties Inc was established in 2012, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Health Services business, which does work in the B2C market, and is classified as a Health Services, under code number 621999 by the NAICS.

If you are seeking more information, feel free to contact Vasco A Rodriguez at the company’s single location by writing to 51 North Doverplum Avenue, Kissimmee, Florida FL 34758 or by phoning (407) 583-7130. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Mid-Florida Medical Specialties Inc
Contact Person: Vasco A Rodriguez
Address: 51 North Doverplum Avenue, Kissimmee, Florida 34758
Phone Number: (407) 583-7130
Annual Revenue (USD): $50.000 to $99.999
Founded: 2012
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Health Services
SIC Code: 8099
NAICS Code: 621999
Share This Business:

Mid-Florida Medical Specialties Inc was started in 2012 to provide professional Health Services under the SIC code 8099 and NAICS code 621999. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.

Feel free to contact Vasco A Rodriguez for inquiries that concern Mid-Florida Medical Specialties Inc by calling the company number (407) 583-7130, as your correspondence is most welcome. Additionally, the physical location of the single location of Mid-Florida Medical Specialties Inc can be found at the coordinates 28.148479,-81.453178 as well as the street address 51 North Doverplum Avenue in Kissimmee, Florida 34758.

For its online presence, you may visit Mid-Florida Medical Specialties Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.